Extreme Investor Network

J&J’s cell therapy takes the lead against Bristol Myers competitor

April 9, 2024

J&J cell therapy gains edge over Bristol Myers rival

When it comes to groundbreaking news in the world of business and healthcare, the recent FDA approvals of two competing cell therapies from Bristol Myers Squibb and Johnson & Johnson are causing quite a stir. … Read more

Research Shows that 25% of Gen Z Individuals Seek Therapy After completing their Taxes

April 4, 2024

As an Extreme Investor, understanding the complex world of taxes is crucial to making informed financial decisions. In a recent poll conducted by Cash App Taxes, it was revealed that 1 in 4 Gen X … Read more